Artificial intelligence can potentially revolutionize the development of informed consent materials for clinical trials. This session will explore how AI can potentially enhance and accelerate timelines and improve outcomes while maintaining compliance with health authority regulations. Participants will have the chance to explore the applications of AI and their implications for clinical research and medical writing. 

Learning Objectives: 

1. Explain the potential role of AI in improving the informed consent authoring process for clinical trials.
2. Explore AI-driven strategies to enhance participant understanding and engagement during consent.
3. Evaluate the impact of AI on the efficiency and compliance of the informed consent process.
4. Review ethical considerations and regulatory requirements when using AI in informed consent authoring.